Advertisement

Andere Diabetesformen bei Kindern und Jugendlichen

  • Thomas DanneEmail author
  • Olga Kordonouri
  • Karin Lange
Chapter

Zusammenfassung

Der insulinpflichtige, autoimmun-bedingte Typ-1-Diabetes ist die häufigste Diabetesform bei Kindern und Jugendlichen. Es gibt jedoch andere Diabetesformen, die sich bereits im Kindes- und Jugendalter manifestieren können. Dazu gehören der Typ-2-Diabetes bei übergewichtigen bzw. adipösen Kindern mit meistens positiver Familienanamnese für Typ-2-Diabetes und klinischen Zeichen eines Hyperinsulinismus (z. B. Acanthosis nigricans), Diabetes bei genetischen Defekten (z. B. „maturity onset diabetes of the young“, MODY; DIDMOAD-Syndrom, neonataler Diabetes), Diabetes im Rahmen anderer Grunderkrankungen (z. B. bei zystischer Fibrose) sowie der medikamentös induzierter Diabetes.

Literatur und Webseiten

  1. Awa WL, Fach E, Krakow E, et al. (2012) Type 2 Diabetes from the pediatric to the geriatric age: Analysis of gender and obesity among 120.183 patients of the German/Austrian DPV database. Eur J Endocrinol 167: 245–254PubMedGoogle Scholar
  2. Copeland KC, Silverstein J, Moore KR, Prazar GE, Raymer T, Shiffman RN, Springer SC, Thaker VV, Anderson M, Spann SJ, Flinn SK; American Academy of Pediatrics (2013) Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents. Pediatrics 131:364–382PubMedCrossRefGoogle Scholar
  3. Danne T, Kordonouri O (2013) Transatlantic differences in the management of T2DM in youth. Nat Rev Endocrinol 9:263–264PubMedCrossRefGoogle Scholar
  4. Diabetes DE, Deutsche Diabetes Hilfe (2014) Deutscher Gesundheitsbericht-Diabetes 2014. Kirchheim, MainzGoogle Scholar
  5. Edghill EL, Flanagan SE, Patch AM, Boustred C, Parrish A, Shields B, Shepherd MH, Hussain K, Kapoor RR, Malecki M, MacDonald MJ, Støy J, Steiner DF, Philipson LH, Bell GI; Neonatal Diabetes International Collaborative Group, Hattersley AT, Ellard S (2008) Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57: 1034–1042PubMedCrossRefGoogle Scholar
  6. Fazeli Farsani S, van der Aa MP, van der Vorst MJ, Knibbe CAJ, de Boer A (2012) Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia 56:1471–1488CrossRefGoogle Scholar
  7. Flanagan SE, Clauin S, Bellanné-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, Ellard S (2009). Update of mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 30: 170–180PubMedCrossRefGoogle Scholar
  8. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT (2006) Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 49:1190–1197PubMedCrossRefGoogle Scholar
  9. Gloyn AL, Pearson ER, Antcliff JF et al. (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350: 1838–1849PubMedCrossRefGoogle Scholar
  10. Gloyn AL, Diatloff-Zito C, Edghill EL, Bellanné-Chantelot C, Nivot S, Coutant R, Ellard S, Hattersley AT, Robert JJ (2006) KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 14:824–830PubMedCrossRefGoogle Scholar
  11. Koloušková S, Zemková D, Bartošová J, Skalická V, Šumník Z, Vávrová V, Lebl J (2011) Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study. J Pediatr Endocrinol Metab 24: 449–454PubMedGoogle Scholar
  12. Lopez de Heredia M, Cleries R, Nunes V (2013) Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype. Genet Med 15: 497–506CrossRefGoogle Scholar
  13. Moran A, Pillay K, Becker DJ, Acerini CL (2014) ISPAD Clinical Practice Consensus Guidelines. Management of cystic-fibrosis related diabetes. Pediatr Diabetes 15 (Suppl 20): 65–76Google Scholar
  14. Neu A, Feldhahn L, Ehehalt S, Hub R, Ranke MB, DIARY group Baden-Württemberg (2009) Type 2 diabetes mellitus in children and adolescents is still a rare disease in Germany: a population-based assessment of the prevalence of type 2 diabetes and MODY in patients aged 0-20 years. Pediatr Diabetes 10:468–473PubMedCrossRefGoogle Scholar
  15. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Sovik O, Polak M, Hattersley AT (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467–477PubMedCrossRefGoogle Scholar
  16. O’Riordan SM, Dattani MT, Hindmarsh PC (2010) Cystic fibrosis-related diabetes in childhood. Horm Res Paediatr 73:15–24PubMedCrossRefGoogle Scholar
  17. Pinhas-Hamiel O, Zeitler P (2005) The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 146: 693–700PubMedCrossRefGoogle Scholar
  18. Rohayem J, Ehlers C, Wiedemann B, Holl R, Oexle K, Kordonouri O, Salzano G, Meissner T, Burger W, Schober E, Huebner A, Lee-Kirsch MA; Wolfram Syndrome Diabetes Writing Group (2011) Diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype Diabetes Care 34:1503–1510PubMedCrossRefPubMedCentralGoogle Scholar
  19. Rubio-Cabezas O, Hattersley AT, Njolstad PR, Mlynarski W, Elland S, White N, Chi DV, Craig ME (2014) ISPAS Clinical Practice Consensus Guidelines. The Diagnosis and Management of Monogenic Diabetes. Pediatr. Diabetes 15 (Suppl 20): 47–64Google Scholar
  20. TODAY Study Group, Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S, Cuttler L, Nathan DM, Tollefsen S, Wilfley D, Kaufman F (2012) N Engl J Med 366:2247–2256PubMedCrossRefGoogle Scholar
  21. Wildin RS, Smyk-Pearson S, Filipovich AH (2002). Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39:537–545PubMedCrossRefPubMedCentralGoogle Scholar
  22. Zeitler P, Fu J, Tandon N, Nadean K, Urakami T, Bartlett T, Maahs D (2014) ISPAD Clinical Practice Consensus Guidelines. Type 2 Diabetes. Pediatr Diabetes 15 (Suppl 2): 26–46Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Kinderkrankenhaus AUF DER BULTHannoverDeutschland
  2. 2.Medizinische Hochschule Hannover (MHH)HannoverDeutschland

Personalised recommendations